抗血栓剂问卷工具用于评估社区药房中联合抗血栓剂疗法
Renate C A E van Uden, Barzo Sulaiman1, Patricia A M Pols2
1From the Pharmacy Foundation of Haarlem Hospitals, Haarlem, the Netherlands.
Journal of patient safety
|June 26, 2024
概括
一个新的抗血栓问卷工具有效地识别了可能不正确的抗血栓治疗的患者. 这种经过验证的工具在社区药房评估药物的适当性方面表现出高度的灵敏度和特异性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床药房 临床药房
- 患者安全 患者安全
背景情况:
- 抗血栓治疗对于预防血栓事件至关重要.
- 确保抗血栓治疗的适当性是患者安全的一个关键方面.
- 社区药房在药物管理和患者咨询方面发挥着至关重要的作用.
研究的目的:
- 评估一种新型抗血栓素问卷工具的诊断准确性.
- 将问卷工具的性能与医院医疗记录进行比较,以评估抗血栓治疗.
- 确定问卷是否可以识别潜在不正确的抗血栓治疗患者.
主要方法:
- 这是一项涉及荷兰8家社区药房95名患者的横截面研究.
- 开发和使用一个标准化的抗血栓素问卷工具.
- 药剂师根据患者的反应和医疗记录对抗血栓治疗正确性的评估.
主要成果:
- 抗血栓性问卷工具在识别可能不正确的抗血栓性治疗时实现了100%的灵敏度和94%的特异性.
- 使用该工具的药剂师评估发现15%的患者有潜在的错误治疗.
- 医疗记录发现9%的患者有潜在的错误治疗.
结论:
- 抗血栓性问卷工具是评估患者抗血栓性治疗适当性的可靠工具.
- 这个工具可以在社区药房设置中有效地实施,以标记需要进一步审查其抗血栓治疗方案的患者.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
675
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
517
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
517
Therapeutic Index
4.2K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
4.2K
Assessment of the Cardiovascular System I: Subjective Data
315
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
315
Pharmacovigilance
817
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
817


